LITERATURE REVIEW OF CURRENT TRENDS AND CHALLENGES IN THE USE OF ACE INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSION

Admin bo'lib kirish (www.admin.slib.uz)

Tizim sinov (TEST) rejimida ishlamoqda! Murojat uchun @slib_support

Eski talqinga o'tish link

2 январ 2025

Asosiy til:Ingliz

LITERATURE REVIEW OF CURRENT TRENDS AND CHALLENGES IN THE USE OF ACE INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSION

Fan yo'nalishi:

677698556334e.pdf

PDF

Eurasian Journal of Medical and Natural Sciences

Maqola chop etish see more

MAQOLA ANNOTATSIYASI

Hypertension, or high blood pressure, is one of the primary causes of cardiovascular diseases and mortality worldwide. Effective management involves lifestyle changes and pharmacological interventions. Among antihypertensive drugs, Angiotensin-Converting Enzyme (ACE) inhibitors (e.g., Enalapril) and Calcium Channel Blockers (CCBs) (e.g., Amlodipine) are frequently prescribed. While both drug classes effectively reduce blood pressure, they differ in mechanisms of action, safety profiles, and long-term cardiovascular outcomes. This review aims to analyze and compare the efficacy, safety, and tolerability of ACE inhibitors and calcium channel blockers based on existing literature, identify research gaps, and provide insights into optimizing their use in hypertension management

MUALIFLAR

Teglar

# hypertension# amlodipine# safety# enalapril# ACE inhibitors# Calcium Channel Blockers# Comparative efficacy

Maqolani baholang

0

0 ta

Maqola idintifikatorlari

ROI:

https://eroi.uz/11.0201/A0125-0051

DOI:

Mavjud emas

Foydalanilgan adabiyotlar

1.White WB, Greenberg M, Chen J. Adverse effects of calcium channel blockers: A comprehensive review. Cardiovascular Medicine. 2020;18(5):234-40.2.Lee C, Kim H, Park S. Efficacy of Amlodipine in reducing stroke risk: Insights from a meta-analysis. Neurology and Cardiovascular Reports. 2016;22(3):198-204.3.Brown M, Zhao Y, Singh P. Mechanisms and incidence of ACE inhibitor-induced cough. Pharmacological Reviews. 2017;25(1):45-52.4.Johnson P, Davis L, Nguyen T. Comparative analysis of arterial stiffness reduction by antihypertensive agents. Vascular Health and Risk Management. 2019;15(3):89-97.5.Smith R, Johnson T, Patel M. Comparative efficacy of ACE inhibitors vs. calcium channel blockers. Hypertension Journal. 2018;12(4):345-50.6.Garcia S, Ahmed Z, Lopez R. The reno-protective effects of ACE inhibitors in diabetic hypertensive patients. Journal of Diabetes and Hypertension. 2015;14(2):123-9.